SLXN Scorecard | SILEXION THERAPEUTICS CORP

SILEXION THERAPEUTICS CORP (SLXN) Scorecard

2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.

40 QUARTERS × 3 ROAST BATTLES

7/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

Quarter	Total return	Revenue growth	EPS growth
2026-Q20/3	LoseSLXN / S&P -80.08% / 15.20%	LoseSLXN / S&P SLXN unavailable / 15.00%	LoseSLXN / S&P -119.41% / 50.40%
2026-Q10/3	LoseSLXN / S&P -33.33% / -4.33%	LoseSLXN / S&P SLXN unavailable / 11.30%	LoseSLXN / S&P -60.75% / 27.70%
2025-Q40/3	LoseSLXN / S&P -43.53% / 2.65%	LoseSLXN / S&P SLXN unavailable / 9.00%	LoseSLXN / S&P -61.01% / 13.40%
2025-Q30/3	LoseSLXN / S&P -72.02% / 8.12%	LoseSLXN / S&P SLXN unavailable / 4.61%	LoseSLXN / S&P -159.01% / 13.45%
2025-Q20/3	LoseSLXN / S&P -26.36% / 10.94%	LoseSLXN / S&P SLXN unavailable / 4.83%	LoseSLXN / S&P -115.34% / 10.63%
2025-Q11/3	LoseSLXN / S&P -45.27% / -4.27%	LoseSLXN / S&P SLXN unavailable / 4.98%	WinSLXN / S&P 91.26% / 10.57%
2024-Q41/3	WinSLXN / S&P 282.86% / 2.41%	LoseSLXN / S&P SLXN unavailable / 5.25%	LoseSLXN / S&P SLXN unavailable / 6.15%
2024-Q30/3	LoseSLXN / S&P -95.53% / 5.89%	LoseSLXN / S&P SLXN unavailable / 5.89%	LoseSLXN / S&P SLXN unavailable / 6.11%
2024-Q21/3	WinSLXN / S&P 4.72% / 4.28%	LoseSLXN / S&P SLXN unavailable / 5.38%	LoseSLXN / S&P SLXN unavailable / 5.12%
2024-Q10/3	LoseSLXN / S&P 3.41% / 10.56%	LoseSLXN / S&P SLXN unavailable / 5.71%	LoseSLXN / S&P SLXN unavailable / 5.59%
2023-Q40/3	LoseSLXN / S&P -0.18% / 11.69%	LoseSLXN / S&P SLXN unavailable / 6.81%	LoseSLXN / S&P SLXN unavailable / 7.78%
2023-Q31/3	WinSLXN / S&P 3.23% / -3.27%	LoseSLXN / S&P SLXN unavailable / 7.52%	LoseSLXN / S&P SLXN unavailable / -5.03%
2023-Q20/3	LoseSLXN / S&P 2.43% / 8.74%	LoseSLXN / S&P SLXN unavailable / 9.50%	LoseSLXN / S&P SLXN unavailable / -8.57%
2023-Q10/3	LoseSLXN / S&P 2.09% / 7.50%	LoseSLXN / S&P SLXN unavailable / 10.77%	LoseSLXN / S&P SLXN unavailable / -15.69%
2022-Q40/3	LoseSLXN / S&P 1.41% / 7.56%	LoseSLXN / S&P SLXN unavailable / 11.88%	LoseSLXN / S&P SLXN unavailable / -17.99%
2022-Q31/3	WinSLXN / S&P 1.12% / -4.88%	LoseSLXN / S&P SLXN unavailable / 13.47%	LoseSLXN / S&P SLXN unavailable / -1.41%
2022-Q21/3	WinSLXN / S&P 0.41% / -16.10%	LoseSLXN / S&P SLXN unavailable / 13.71%	LoseSLXN / S&P SLXN unavailable / 11.04%
2022-Q11/3	WinSLXN / S&P 1.03% / -4.60%	LoseSLXN / S&P SLXN unavailable / 15.97%	LoseSLXN / S&P SLXN unavailable / 42.23%
2021-Q40/3	LoseSLXN / S&P -0.21% / 11.03%	LoseSLXN / S&P SLXN unavailable / 15.00%	LoseSLXN / S&P SLXN unavailable / 96.40%
2021-Q30/3	LoseSLXN / S&P 0.52% / 0.58%	LoseSLXN / S&P SLXN unavailable / 10.77%	LoseSLXN / S&P SLXN unavailable / 69.42%
2021-Q20/3	LoseSLXN / S&P SLXN unavailable / 8.55%	LoseSLXN / S&P SLXN unavailable / 6.58%	LoseSLXN / S&P SLXN unavailable / 51.81%
2021-Q10/3	LoseSLXN / S&P SLXN unavailable / 6.17%	LoseSLXN / S&P SLXN unavailable / -1.06%	LoseSLXN / S&P SLXN unavailable / 7.39%
2020-Q40/3	LoseSLXN / S&P SLXN unavailable / 12.15%	LoseSLXN / S&P SLXN unavailable / -3.72%	LoseSLXN / S&P SLXN unavailable / -33.42%
2020-Q30/3	LoseSLXN / S&P SLXN unavailable / 8.93%	LoseSLXN / S&P SLXN unavailable / -2.04%	LoseSLXN / S&P SLXN unavailable / -27.10%
2020-Q20/3	LoseSLXN / S&P SLXN unavailable / 20.54%	LoseSLXN / S&P SLXN unavailable / -0.46%	LoseSLXN / S&P SLXN unavailable / -27.11%
2020-Q10/3	LoseSLXN / S&P SLXN unavailable / -19.60%	LoseSLXN / S&P SLXN unavailable / 3.47%	LoseSLXN / S&P SLXN unavailable / -14.75%
2019-Q40/3	LoseSLXN / S&P SLXN unavailable / 9.07%	LoseSLXN / S&P SLXN unavailable / 5.36%	LoseSLXN / S&P SLXN unavailable / 2.99%
2019-Q30/3	LoseSLXN / S&P SLXN unavailable / 1.70%	LoseSLXN / S&P SLXN unavailable / 5.02%	LoseSLXN / S&P SLXN unavailable / 0.21%
2019-Q20/3	LoseSLXN / S&P SLXN unavailable / 4.30%	LoseSLXN / S&P SLXN unavailable / 6.64%	LoseSLXN / S&P SLXN unavailable / 8.65%
2019-Q10/3	LoseSLXN / S&P SLXN unavailable / 13.65%	LoseSLXN / S&P SLXN unavailable / 8.12%	LoseSLXN / S&P SLXN unavailable / 14.29%
2018-Q40/3	LoseSLXN / S&P SLXN unavailable / -13.52%	LoseSLXN / S&P SLXN unavailable / 9.05%	LoseSLXN / S&P SLXN unavailable / 18.23%
2018-Q30/3	LoseSLXN / S&P SLXN unavailable / 7.71%	LoseSLXN / S&P SLXN unavailable / 10.21%	LoseSLXN / S&P SLXN unavailable / 19.06%
2018-Q20/3	LoseSLXN / S&P SLXN unavailable / 3.43%	LoseSLXN / S&P SLXN unavailable / 9.03%	LoseSLXN / S&P SLXN unavailable / 14.46%
2018-Q10/3	LoseSLXN / S&P SLXN unavailable / -0.76%	LoseSLXN / S&P SLXN unavailable / 7.68%	LoseSLXN / S&P SLXN unavailable / 12.46%
2017-Q40/3	LoseSLXN / S&P SLXN unavailable / 6.64%	LoseSLXN / S&P SLXN unavailable / 7.03%	LoseSLXN / S&P SLXN unavailable / 13.82%
2017-Q30/3	LoseSLXN / S&P SLXN unavailable / 4.48%	LoseSLXN / S&P SLXN unavailable / 5.68%	LoseSLXN / S&P SLXN unavailable / 17.57%
2017-Q20/3	LoseSLXN / S&P SLXN unavailable / 3.09%	LoseSLXN / S&P SLXN unavailable / 4.83%	LoseSLXN / S&P SLXN unavailable / 17.74%
2017-Q10/3	LoseSLXN / S&P SLXN unavailable / 6.07%	LoseSLXN / S&P SLXN unavailable / 3.67%	LoseSLXN / S&P SLXN unavailable / 13.32%
2016-Q40/3	LoseSLXN / S&P SLXN unavailable / 3.82%	LoseSLXN / S&P SLXN unavailable / 2.09%	LoseSLXN / S&P SLXN unavailable / 7.05%
2016-Q30/3	LoseSLXN / S&P SLXN unavailable / 3.85%	LoseSLXN / S&P SLXN unavailable / 0.20%	LoseSLXN / S&P SLXN unavailable / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

Metric	SLXN total return	S&P 500 Total Return Index
Total return	-99.51%	20.78%
Annualized return	-99.51%	20.78%

5Y · 2021-09-01 to 2026-08-27

Metric	SLXN total return	S&P 500 Total Return Index
Total return	-99.98%	83.14%
Annualized return	-80.98%	12.86%

10Y · 2021-04-07 to 2026-08-27

Metric	SLXN total return	S&P 500 Total Return Index
Total return	-99.98%	319.30%
Annualized return	-56.55%	15.41%

Calculation rules

window: Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis: Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule: Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency: Quarter endpoints only.
fundamentals: Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
CURIS INC (CRIS)	United States	$0.002B	-0.05
Calidi Biotherapeutics, Inc. (CLDI)	United States	$0.003B
VivoSim Labs, INC. (VIVS)	United States	$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)	United States	$0.003B	-0.32
PharmaCyte Biotech, Inc. (PMCB)	United States	$0.005B
AIM ImmunoTech Inc. (AIM)	United States	$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)	United States	$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)	United States	$0.007B
TScan Therapeutics, Inc. (TCRX)	United States	$0.008B	-1.23
Senti Biosciences Holdings, Inc. (SNTI)	United States	$0.011B	-0.70